Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
PUT
FedEx
FDX
$74.7B
| $19M | ﹤0.01% |
109,800
+11,300
| +11% | +$1.88M |
|
2002
CALL
GDS Holdings
GDS
$6.38B
| $19M | ﹤0.01% |
+921,800
| New | +$14.1M |
|
2003
Gen Digital
GEN
$16.8B
| $19M | ﹤0.01% |
885,694
-781,110
| -47% | -$17.3M |
|
2004
ARK Genomic Revolution ETF
ARKG
$1.63B
| $19M | ﹤0.01% |
672,112
-675,515
| -50% | -$21.4M |
|
2005
Minerals Technologies
MTX
$2.34B
| $19M | ﹤0.01% |
312,138
-71,760
| -19% | -$4.07M |
|
2006
PUT
American Airlines Group
AAL
$10.6B
| $18.9M | ﹤0.01% |
1,489,000
-565,900
| -28% | -$7.67M |
|
|
PRO
2007
DELISTED
PROS Holdings
PRO
| $18.9M | ﹤0.01% |
780,202
+302,020
| +63% | +$7.41M |
|
2008
Ziff Davis
ZD
$1.88B
| $18.8M | ﹤0.01% |
237,241
-28,030
| -11% | -$2.26M |
|
|
ITCI
2009
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.8M | ﹤0.01% |
354,433
-292,813
| -45% | -$14.7M |
|
2010
Affirm
AFRM
$25.6B
| $18.8M | ﹤0.01% |
1,939,242
+416,320
| +27% | +$6.27M |
|
|
CAJ
2011
DELISTED
Canon, Inc.
CAJ
| $18.7M | ﹤0.01% |
862,320
-440,279
| -34% | -$9.81M |
|
2012
PUT
Alcoa
AA
$12.5B
| $18.7M | ﹤0.01% |
411,100
+312,900
| +319% | +$13.6M |
|
2013
CALL
Logitech
LOGI
$14.7B
| $18.7M | ﹤0.01% |
300,000
+170,000
| +131% | +$9.3M |
|
2014
Insperity
NSP
$1.96B
| $18.7M | ﹤0.01% |
164,322
-94,471
| -37% | -$10.7M |
|
2015
Rithm Capital
RITM
$5.55B
| $18.6M | ﹤0.01% |
2,277,100
-266,840
| -10% | -$2.23M |
|
|
MNTV
2016
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $18.6M | ﹤0.01% |
2,657,481
+1,954,039
| +278% | +$14.1M |
|
2017
Allison Transmission
ALSN
$9.64B
| $18.6M | ﹤0.01% |
446,624
-184,320
| -29% | -$7.57M |
|
2018
Bankunited
BKU
$3.37B
| $18.6M | ﹤0.01% |
546,851
+115,667
| +27% | +$4.08M |
|
2019
CALL
American Tower
AMT
$79.8B
| $18.5M | ﹤0.01% |
87,500
-5,500
| -6% | -$1.14M |
|
2020
Invesco S&P 500 High Beta ETF
SPHB
$1.01B
| $18.5M | ﹤0.01% |
297,150
+32,115
| +12% | +$2.02M |
|
2021
CALL
Alcon
ALC
$33.9B
| $18.5M | ﹤0.01% |
270,000
+35,000
| +15% | +$2.23M |
|
2022
Pitney Bowes
PBI
$2.46B
| $18.5M | ﹤0.01% |
4,867,871
-243,462
| -5% | -$821K |
|
2023
ASE Group
ASX
$81.9B
| $18.5M | ﹤0.01% |
2,946,495
+1,135,901
| +63% | +$6.65M |
|
2024
Xencor
XNCR
$1.48B
| $18.5M | ﹤0.01% |
708,787
+58,717
| +9% | +$1.64M |
|
2025
PUT
XPO
XPO
$23B
| $18.4M | ﹤0.01% |
554,100
-1,021,525
| -65% | -$34.4M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.